Back to today’s briefing

Story perspectives

AstraZeneca Halts £200M Investment, Threatening 1,000 Jobs

9/13/2025

43 8 Full Breakdown

Summary

Story summary

AstraZeneca has paused a £200m investment in a Cambridge research site, affecting the UK pharmaceutical sector.
The project, announced in March 2024, aimed to create 1,000 jobs.
This decision follows Merck's cancellation of a £1bn UK expansion due to insufficient government investment.
AstraZeneca's spokesperson stated they regularly reassess investment needs.
NHS medicine spending has declined from 15% to 9% of the budget over the past decade.

1 of 1

Story summary

AstraZeneca has paused a £200m investment in a Cambridge research site, affecting the UK pharmaceutical sector.
The project, announced in March 2024, aimed to create 1,000 jobs.
This decision follows Merck's cancellation of a £1bn UK expansion due to insufficient government investment.
AstraZeneca's spokesperson stated they regularly reassess investment needs.
NHS medicine spending has declined from 15% to 9% of the budget over the past decade.